跳至主要内容
临床试验/ACTRN12617001242314
ACTRN12617001242314招募中不适用

Endoscopic Ultrasound Guided portal vein sampling as an ultimate staging procedure in patients with pancreatic cancer: a feasibility study.

The Royal Adelaide Hospital0 个研究点目标入组 30 人开始时间: 2017年8月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 30 patients who are referred to our unit for EUS guided FNA for either suspected (i) metastatic pancreatic cancer; (ii) locally advanced pancreatic cancer or (iii) resectable pancreatic cancer will be recruited for EUS guided portal vein sampling.
  • i- metastatic pancreatic cancer: imaging evidence of a pancreatic mass with overt discrete lesion(s) in the liver or distant organs.
  • ii- locally advanced pancreatic cancer: imaging evidence of a pancreatic mass that involved the adjacent organs or vasculatures (SMV, SMA, PV or hepatic artery), without overt evidence of hepatic or distant metastasis.
  • iii- resectable pancreatic cancer: imaging evidence of an isolate mass in the pancreas without involvement of adjacent organs, vasculatures or distant metastasis.

排除标准

  • 1. Coagulopathy or thrombocytopenia.
  • 2. Complete portal vein thrombosis, especially those extending into the hilum and liver.
  • 3. Portal Hypertension (detected via EUS )

研究者

发起方
The Royal Adelaide Hospital

相似试验